Universe Pharmaceuticals Balance Sheet (2020-2026)

Reported Financials

Universe Pharmaceuticals Quarterly Balance Sheet

Periods 12 quarters

Latest Mar 2026

Universe Pharmaceuticals reported total assets of $0.07B and total liabilities of -$55644.99B for the quarter ended Mar 2026, up 44.6% year over year. This balance sheet covers 12 quarters of results from Sep 2020 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2020	Mar2021	Sep2021	Mar2022	Sep2022	Mar2023	Sep2023	Mar2024	Sep2024	Mar2025	Sep2025	Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.01B	0.04B	0.01B	0.01B	5.71B	0.01B	5.29B	0.01B	0.03B	0.05B	33.59B	0.03B
Short-term InvestmentsInvestments (Current)			0.01B	0.00B	0.01B	0.01B	0.00B	2,527.60B	1.38B			1,490.20B
Cash & Current Investments	0.01B	0.04B	0.02B	0.01B	5.72B	0.03B	5.29B	2,527.61B	1.41B	0.05B	33.59B	1,490.23B
Receivables - NetNet Receivables	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	14,384.23B	12.91B	10,170.41B	0.01B	14,956.06B
Receivables - OtherOther Receivables			0.00B	0.00B			0.00B		5.67B	3,355.32B	0.00B	7,180.73B
Receivables	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B	14,384.23B	18.57B	13,525.73B	0.02B	22,136.79B
Raw Materials			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.98B		0.00B	0.00B
Work In Process				0.00B		0.00B
Finished Goods			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	1.14B		0.00B	0.00B
Inventory	1,906.23B	0.00B	0.00B	0.00B	2,206.49B	0.00B	3,343.27B	3,386.05B	1,737.05B	3,565.95B	2,193.18B	1,979.80B
Prepaid Assets		0.00B	0.00B	0.00B	1,724.10B	0.00B	37.18B	539.24B	852.42B	39.18B	39.94B	41.22B
Current Assets	23,279.92B	0.06B	0.05B	0.05B	41,505.68B	0.05B	25,269.71B	33,530.13B	0.04B	65,025.54B	53,603.68B	55,209.42B
Non-Current Assets
Construction in Progress			0.01B	0.01B	9,326.30B	0.01B	9,093.00B	9,225.73B	9,492.20B	9,191.85B	8,869.57B	9,114.60B
Property, Plant & Equipment (Net)PP&E (Net)	4,428.06B	0.00B	0.00B	0.00B	4,250.64B	0.00B	3,699.97B	3,523.00B	3,568.05B	3,289.11B	3,583.55B	3,787.57B
Long-Term Investments	735.00B	0.00B	744.92B	0.00B	702.89B	0.00B	0.70B	692.49B	0.01B	689.02B	702.35B	724.85B
Intangibles	174.78B	0.00B	0.00B	0.00B	157.45B	0.00B	148.58B	147.65B	262.88B	266.78B	296.79B	309.75B
Goodwill & Intangibles	174.78B	0.00B	0.00B	0.00B	157.45B	0.00B	148.58B	147.65B	262.88B	266.78B	296.79B	309.75B
Long-Term Deferred Tax	186.54B	0.00B	0.00B	0.00B	1,347.67B	0.00B	599.08B
Other Non-Current Assets	443.71B				0.00B	0.00B	35.86B	96.14B	0.04B
Non-Current Assets	5,524.38B	0.01B	0.02B	0.02B	18,034.19B	0.02B	16,454.78B	15,900.98B	16,315.61B	15,641.61B	15,699.76B	16,256.28B
Assets	28,804.30B	0.07B	0.07B	0.07B	0.06B	0.07B	41,724.48B	0.05B	0.05B	80,667.16B	69.30B	0.07B
Liabilities
Current Liabilities
Accounts Payables	2,691.19B	0.01B	0.01B	0.00B	3,075.39B	0.01B	4,585.28B	7,763.98B	4,914.76B	7,400.65B	1,669.79B	3,754.36B
Notes Payables	2,646.00B	0.00B	0.00B	0.00B	3,936.18B	0.00B	5,482.46B	4,431.95B	5,856.70B	5,663.73B	7,149.88B	7,378.95B
Payables	5,337.19B	0.01B	0.01B	0.01B	7,011.58B	0.02B	10,067.74B	12,195.93B	10,771.47B	13,064.39B	8,819.67B	11,133.31B
Accumulated Expenses			0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.05B
Other Accumulated Expenses	956.49B	0.69B	0.00B	7.29B	3,379.26B	0.01B	540.10B	5,515.16B	6,900.58B	8,585.19B	446.55B	157.29B
Short term Debt											2,107.04B
Current Taxes	0.00B	0.00B	0.00B	0.00B	167.35B	0.00B	434.76B	172.37B	1,021.18B	119.48B	640.78B	655.65B
Current Deferred Revenue											40.71B	42.01B
Total Current Liabilities	8,001.39B	0.02B	0.01B	0.01B	13,097.55B	0.02B	13,754.33B	20,609.54B	20,312.97B	23,415.15B	13,173.93B	13,646.09B
Non-Current Liabilities
Non-Current Debt								2,077.48B	2,137.48B	2,067.05B		2,174.54B
Preferred Stock Liabilities							0.00B
Other Non-Current Liabilities								0.00B
Total Non-Current Liabilities								-26744.05B	2,137.48B
Total Liabilities	28,804.28B	0.02B	0.02B	0.01B	-35.27B	0.02B	41,696.51B	-26744.05B	0.00B	80,667.10B	-56060.21B	-55644.99B
Shareholder's Equity
Total Debt	2,646.00B	0.00B	0.00B	0.00B	3,936.18B	0.00B	5,482.46B	6,509.43B	7,994.19B	7,730.79B	9,256.92B	9,553.49B
Common Equity	0.02B	0.05B	0.05B	0.06B	35.33B	0.05B	27.97B	26,744.10B	0.05B	0.06B	56,129.51B	55,645.06B
Liabilities and Shareholders Equity	28,804.30B	0.07B	0.07B	0.07B	0.06B	0.07B	41,724.48B	0.05B	0.05B	80,667.16B	69.30B	0.07B
Retained Earnings	13,738.98B	0.02B	0.03B	0.03B	16,322.36B	0.02B	-1444.27B	-2942.15B	-0.01B	-13456.32B	-13843.62B	-15398.44B
Preferred Shares		0.00B	0.00B	0.00B	0.00B					0.01B		0.00B

Universe Pharmaceuticals Balance Sheet API

Pull Universe Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=UPC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "UPC", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=UPC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Universe Pharmaceuticals UPC Balance Sheet (2020-2026)

Universe Pharmaceuticals Quarterly Balance Sheet

Universe Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password